• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Resection of hepatocellular carcinoma.

作者信息

Franco D, Usatoff V

机构信息

Hôpital Antoine Béclère 157 rue de la Porte de Trivaux, Clamart 92140, France.

出版信息

Hepatogastroenterology. 2001 Jan-Feb;48(37):33-6.

PMID:11268993
Abstract

The majority of hepatocellular carcinoma occurs in patients with liver cirrhosis. Although the tumors are often discovered at an early stage during surveillance of these patients, the underlying cirrhosis renders the surgery more difficult and exposes the patients to higher rates of postoperative morbidity and mortality than occurs in other types of liver surgery. Over the past 20 years surgeons have developed new surgical procedures and techniques to firstly reduce the unnecessary resection of liver parenchyma and to decrease intraoperative blood loss. Better patient selection and understanding of prognostic factors will hopefully result in a further decrease in operative risk and postoperative recurrence. Adjuvant chemotherapy may prove effective in reducing the postoperative recurrence but at this stage surgery still remains as the best treatment for patients with recurrent tumor which is accessible to resection.

摘要

相似文献

1
Resection of hepatocellular carcinoma.
Hepatogastroenterology. 2001 Jan-Feb;48(37):33-6.
2
Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.共存肝硬化对符合米兰标准的肝细胞癌患者肝部分切除术后结局的影响:293例患者分析
Surgery. 2007 Nov;142(5):685-94. doi: 10.1016/j.surg.2007.05.009.
3
Accompanying liver cirrhosis as a risk factor for recurrence after resection of solitary hepatocellular carcinoma.伴有肝硬化作为孤立性肝细胞癌切除术后复发的一个危险因素。
Hepatogastroenterology. 2003 Nov-Dec;50(54):1991-5.
4
Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.直径大于或等于10厘米的肝细胞癌的肝切除术
Hepatogastroenterology. 2002 Mar-Apr;49(44):518-23.
5
Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.对合并肝硬化的肝细胞癌进行肝切除。
Hepatogastroenterology. 2002 Sep-Oct;49(47):1363-8.
6
Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis.肝硬化肝细胞癌肝切除的预后因素:单因素和多因素分析
J Surg Oncol. 2002 Dec;81(4):195-202. doi: 10.1002/jso.10178.
7
Results of surgical resection for hepatocellular carcinoma.肝细胞癌手术切除的结果。
Acta Chir Belg. 1993 May-Jun;93(3):98-101.
8
Longterm prognosis after hepatic resection for small hepatocellular carcinoma.小肝细胞癌肝切除术后的长期预后
J Am Coll Surg. 2004 Mar;198(3):356-65. doi: 10.1016/j.jamcollsurg.2003.10.017.
9
Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.非肝硬化性肝脏来源的肝细胞癌肝切除的长期结果
Arch Surg. 2004 Mar;139(3):320-5; discussion 326. doi: 10.1001/archsurg.139.3.320.
10
Liver resection in advanced hepatocellular carcinoma.晚期肝细胞癌的肝切除术
Hepatogastroenterology. 2001 Jan-Feb;48(37):46-50.

引用本文的文献

1
Computational and Analysis of Plumbagin's Molecular Mechanism for the Treatment of Hepatocellular Carcinoma.白花丹醌治疗肝细胞癌分子机制的计算与分析
Front Pharmacol. 2021 Apr 12;12:594833. doi: 10.3389/fphar.2021.594833. eCollection 2021.
2
Targeting Liver Cancer Stem Cells: An Alternative Therapeutic Approach for Liver Cancer.靶向肝癌干细胞:一种肝癌的替代治疗方法
Cancers (Basel). 2020 Sep 24;12(10):2746. doi: 10.3390/cancers12102746.
3
Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer.
原发性肝癌周围肝组织中的微转移及手术切缘的最小长度
World J Gastroenterol. 2007 Sep 7;13(33):4498-503. doi: 10.3748/wjg.v13.i33.4498.
4
Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study.经皮乙醇注射与手术切除治疗小肝细胞癌的前瞻性研究。
Ann Surg. 2005 Jul;242(1):36-42. doi: 10.1097/01.sla.0000167925.90380.fe.
5
Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.富血管性肝细胞癌的检测:多层螺旋CT与数字减影血管造影及碘油CT的比较
World J Gastroenterol. 2005 Jan 14;11(2):200-3. doi: 10.3748/wjg.v11.i2.200.
6
Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.联合经动脉化疗栓塞与白及动脉给药治疗大鼠肝肿瘤
World J Gastroenterol. 2003 Dec;9(12):2676-80. doi: 10.3748/wjg.v9.i12.2676.
7
Combined interventional therapies of hepatocellular carcinoma.肝细胞癌的联合介入治疗
World J Gastroenterol. 2003 Sep;9(9):1885-91. doi: 10.3748/wjg.v9.i9.1885.
8
Surgery for large primary liver cancer more than 10 cm in diameter.直径超过10厘米的原发性大肝癌手术。
J Cancer Res Clin Oncol. 2003 Sep;129(9):543-8. doi: 10.1007/s00432-003-0446-6. Epub 2003 Jul 30.
9
The prognostic significance of clinical and pathological features in hepatocellular carcinoma.肝细胞癌临床和病理特征的预后意义
World J Gastroenterol. 2002 Apr;8(2):193-9. doi: 10.3748/wjg.v8.i2.193.